Abbott, Intuitive and J&J kick off medtech earnings as COVID-19 bellwethers

Medtech earnings season starts this week with a batch of results that will give an indication of the state of the industry at this point in the pandemic. Intuitive Surgical and Johnson & Johnson are set to report results that will shed light on the recovery of elective procedures, while Abbott Laboratories will provide insights into the drop in COVID-19 test demand.